EUVIMEDEUVIMED entdecken
Crossref

Indicación del rastreo óseo en la estadificación del cáncer de mama de inicio

L de la Cueva, P Liévano, P Navarro, E Arroyo, M Añaños, M González, M C García, A Fuerte, F Colmenarejo, T Baringo, M D Abós

Revista Española de Medicina Nuclear · 2009

DOI: 10.1016/j.remn.2009.05.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Medicina Nuclear, 2009. Verfasst von L de la Cueva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Nuclear, Hospital Universitario Miguel Servet, Zaragoza, España. ldelacueva@salud.aragon.es. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Evaluate the indication for bone scanning during staging of early breast cancer in the light of scientific evidence to assess the need to modify practices with scant effectiveness. MATERIAL AND METHODS: The bone scans carried out in our Nuclear Medicine Department in 2007 on patients with primary breast cancer were reviewed retrospectively. Results were analyzed in relation to the clinical and histopathologic findings for each tumor. Bone scan results of tumors >2 cm y 3 cm, and pre-treatment clinical stage. RESULTS: Out of 245 bone scans of patients with breast cancer, 237 (97%) were negative for metastatic disease and 8 (3%) were positive. Lesions 2 cm and 3 cm. The bone scan findings did not modify staging in any of the 66 patients with T2 tumors stage IIA, but it did modify staging in 2 of 12 patients with stage IIB tumors. Twenty percent of 15 patients with T3 tumors and 13% of patients with T4 tumors had bone metastasis at time of diagnosis. CONCLUSIONS: Ineffective practices should be modified and bone scanning should not be indicated in patients with early breast cancer Tis, T1 and T2 with tumor

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAged, 80 and overBone NeoplasmsBreast NeoplasmsCarcinomaFemaleHumansMiddle AgedNeoplasm StagingPreoperative CareRadiopharmaceuticalsRetrospective StudiesTechnetium Tc 99m MedronateTomography, Emission-Computed, Single-PhotonUnnecessary Procedures

Substanzen

RadiopharmaceuticalsTechnetium Tc 99m Medronate

Autor:innen und Institutionen

  • Servicio de Medicina Nuclear, Hospital Universitario Miguel Servet, Zaragoza, España. ldelacueva@salud.aragon.es

Zitieren

APA

de la Cueva, L., Liévano, P., Navarro, P., Arroyo, E., Añaños, M., González, M., García, M. C., Fuerte, A., Colmenarejo, F., Baringo, T., & Abós, M. D. (2009). Indicación del rastreo óseo en la estadificación del cáncer de mama de inicio. Revista Española de Medicina Nuclear. https://doi.org/10.1016/j.remn.2009.05.003

Vancouver

de la Cueva L, Liévano P, Navarro P, Arroyo E, Añaños M, González M, et al. Indicación del rastreo óseo en la estadificación del cáncer de mama de inicio. Revista Española de Medicina Nuclear. 2009. doi:10.1016/j.remn.2009.05.003

BibTeX
@article{delaCueva2009,
  author = {de la Cueva, L and Liévano, P and Navarro, P and Arroyo, E and Añaños, M and González, M and García, M C and Fuerte, A and Colmenarejo, F and Baringo, T and Abós, M D},
  title = {Indicación del rastreo óseo en la estadificación del cáncer de mama de inicio},
  journal = {Revista Española de Medicina Nuclear},
  year = {2009},
  doi = {10.1016/j.remn.2009.05.003}
}
Kostenlos starten →